9th Advances Against Aspergillosis and Mucormycosis

Palazzo dei Congressi Lugano, Lugano, Switzerland

27 – 29 February 2020

9th Advances Against Aspergillosis and Mucormycosis

Palazzo dei Congressi Lugano, Lugano, Switzerland

27 – 29 February 2020

9th Advances Against Aspergillosis and Mucormycosis

Palazzo dei Congressi Lugano, Lugano, Switzerland

27 – 29 February 2020

Programme

Go directly to a day’s programme
Thursday | Friday | Saturday

Thursday 27 February 2020 – Day 1

Meet the Professor

08:00 – 08:55ECMM and ISHAM joint session: Excellence centres, fellows, guidelines, educational initiatives, working groups and publishing
Martin Hönigl, MD & Arunaloke Chakrabarti, MD
08:00 – 08:55Kids, difficult asthma and fungus
Andrew Bush, MD
 
09:00 – 09:15Introduction and summary of new antifungal drugs
David W. Denning, MBBS
                               

Aspergillus: Modelling the Host and Beyond

09:20 – 09:45IL-22 and tryptophan metabolism in antifungal host defense
Teresa Zelante, PhD
09:45 – 10:00Selected abstract presentation
10:00 – 10:15Selected abstract presentation
10:15 – 10:30Selected abstract presentation
10:30 – 10:55IL-17 immunity: from Aspergillus to Candida
Petra Bacher, PhD
10:55 – 11:25
Coffee Break

Management for the Next Decade

11:25 – 11:50Genetic signatures: new frontiers?
Juan Sainz, PhD
11:50 – 12:05Selected abstract presentation
12:05 – 12:20Selected abstract presentation
12:20 – 12:35Selected abstract presentation
12:35 – 13:00Individualized genetic-based approach for IA prophylaxis
Pierre-Yves Bochud, MD
13.00 – 14.30
Lunch and Poster Session 1

Airways and Diseases

14:30 – 14:55Respiratory epithelial interaction
Kirk M. Druey, MD
14:55 – 15:10Selected abstract presentation
15:10 – 15:25Selected abstract presentation
15:25 – 15:50Growing new lungs and repairing old ones – any chance?
To be confirmed
15:50 – 16:20
Coffee Break

Aspergillus: Entering the Host and Beyond

16:20 – 16:45Siderophores and fungal pathogenesis
Hubertus Haas, PhD
16:45 – 17:00Selected abstract presentation
17:00 – 17:15Selected abstract presentation
17:15 – 17:40Modelling IA – how close are predicted antifungal targets?
Thomas Walsh, MD PhD
17:40 – 18:45
Welcome Reception

Go directly to a day’s programme
Thursday | Friday | Saturday

Friday 28 February 2020 – Day 2

Meet the Professor

08:00 – 08:55Difficult cases in fungal sinusitis
Tarik Mohsena FRCPC, FACP, DTM&H & Li-Ping Zhu, PhD
08:00 – 08:55How to make a fast and accurate diagnosis – what can the clinician and lab do?
Dea Garcia-Hermoso, PhD & Stéphane Ranque, MD PhD

Emerging Aspergilli

09:00 – 09:25Current epidemiology of invasive fungal infections
Nina Khanna, MD
09:25 – 09:40Selected abstract presentation
09:40 – 10:05Epidemiological surveillance for Aspergillus – is it of any value?
Sophie Loeffert-Frémiot
10:05 – 10:20Selected abstract presentation
10:20 – 10:45Aspergillus calidoustus – epidemiology and outcome
Frederic Lamoth, MD
10:45 – 11:15
Coffee Break

Aspergillus & the Hosts’ Challenge

11:15 – 11:40Regulation of Th2-immunity
David B. Corry, MD
11:40 – 11:55Selected abstract presentation
11:55 – 12:10Selected abstract presentation
12:10 - 12:35The structure and immunogenicity of galactomannan
Nikolay Nifantiev, PhD
12:20 – 13:30
Lunch followed by Poster Viewing


Go directly to a day’s programme
Thursday | Friday | Saturday

Saturday 29 February 2020 – Day 3

Meet the Professor

08:00 – 08:55CLSI/EUCAST: AFST for breakpoints - where we are going?
David R. Andes, MD & Jesús V. Guinea Ortega, PharmD, PhD
07:45 – 08:55Regulatory endpoints for invasive and chronic pulmonary aspergillosis – what is needed?
John Perfect, MD, Oliver Cornely, MD, Marco Cavaleri, PhD & Sumathi Nambiar, MD

Resistance in Aspergillus

09:00 – 09:25Acquiring azole resistant Aspergilli – where from?
To be confirmed
09:25 – 09:40Selected abstract presentation
09:40 – 09:55Selected abstract presentation
09:55 – 10:10Selected abstract presentation
10:10 – 10:35Management of aspergillosis due to azole-resistant Aspergillus fumigatus
Bart-Jan Kullberg, MD PhD
10:35 – 11:05
Coffee Break

Molecular Mechanisms

11:05 – 11:30Recognition of DHN-melanin by C–type lectin receptor
Gordon D. Brown, PhD
11:30 – 11:45Selected abstract presentation
11:45 – 12:00Selected abstract presentation
12:00 – 12:15Selected abstract presentation
12:15 – 12:40Antimicrobial peptides secreted by Aspergillus fumigatus
Sven Krappmann, PhD
12:40 – 14:20
Lunch and Poster Session 2

Mucormycosis Update

14:20 – 14:45One world - one guideline: mucormycosis
Oliver Cornely, MD
14:45 – 15:10Biomarker for aspergillosis & mucormycosis
Vladimir Havlicek, PhD
15:10 – 15:25Selected abstract presentation
15:25 – 15:40Selected abstract presentation
15:40 – 16:05Mucor species & macrophages
Victoriano Garre, PhD
16:05 – 16:35
Coffee Break

Risks for Aspergillus-Related Diseases: Clinical Hot Spots

16:35 – 17:00Chronic pulmonary aspergillosis and NTM – a hellish combination
Yoshitsugu Miyazaki MD PhD
17:00 – 17:15Selected abstract presentation
17:15 – 17:40Biofilm formation by Aspergillus fumigatus – implications for treatment
Don Sheppard, MD
17:40 – 17:55Selected abstract presentation
17:55 – 18:20The new world of inhaled antifungals & biologics – where might it take us?
Richard B. Moss, MD
18:20 – 18:25
Closing
18:30
Snacks and Discussion about AAA 2022